News & Events about Si Bone Inc.
Fourth Quarter revenue of $31.7 - $31.9 million representing growth of approximately 26%Fiscal Year 2022 revenue of $106.1 - $106.3 million representing growth of approximately 18% SANTA CLARA, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated...
SI-BONE (NASDAQ:SIBN Get Rating) had its price target decreased by stock analysts at Morgan Stanley from $21.00 to $18.00 in a research note issued on Friday, Benzinga reports. The firm currently has an overweight rating on the stock. Morgan Stanleys price objective points to a potential upside of ...
Shares of SI-BONE, Inc. (NASDAQ:SIBN Get Rating) have received a consensus rating of Buy from the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that ...
New Indications Include Use with a Broad Class of Commercially Available Rods
iFuse Bedrock Granite
iFuse Bedrock Granite
SANTA CLARA, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), aSilicon Valley-based medical device company dedicated to solving musculoskeletal ...
SI-BONE, Inc. (NASDAQ:SIBN Get Rating) Investment analysts at Jefferies Financial Group lowered their Q4 2022 earnings per share (EPS) estimates for SI-BONE in a note issued to investors on Monday, November 7th. Jefferies Financial Group analyst Y. Li now expects that the company will post earnings ...